May/June 2014

Gazyva by Genentech

May 19, 2014

New Drug Review

Gazyva is a novel anti-CD20 monoclonal antibody approved, in combination with chlorambucil, for the treatment of previously untreated chronic lymphocytic leukemia patients.

Oncology Pharmacy: The Need for Specialization in Specialty Pharmacy

May 19, 2014

Features

The complexities of cancer and the ever-changing medication regimens employed in its treatment call for the specialized competencies of oncology-focused pharmacies. High-touch care and oncology expertise can improve outcomes.

The Role of Independent Specialty Pharmacies in Product Commercialization

May 19, 2014

Features

Pharmaceutical manufacturers are increasingly looking to independent specialty pharmacies to play a key role in the launch of new products, harnessing the power of the independents' ability to devote time and resources to patient care.

Trends in Cancer Care

May 19, 2014

Features

With cancer ranking third among disease states in specialty spending, there is a growing emphasis on programs that focus on cost management and patient adherence to complex medication regimens.

Specialty Is Not Always Pharmacy

May 19, 2014

Editorial

Selection of the right distribution model is of key importance in the launch of a specialty product, where each of the stakeholders has specific needs and requirements that must be met.